Turkey Regulatory Update: First Local Biosimilar, Counterfeits, Reimbursement Issues
This article was originally published in PharmAsia News
The first biosimilar to be produced locally in Turkey has been licensed by the Ministry of Health, operations of an international counterfeit smuggling ring broken, and a campaign launched to have nivolumab reimbursed. The ministry has also reached agreement over the reimbursement of certain drugs, and producers of unsafe medical devices have been fined.
Register for our free email digests: